(Q36248038)

13 August 2017

1 reference

title

Antidepressant-induced manic conversion: a developmentally informed synthesis of the literature (English)

1 reference

13 August 2017

Christine J Lim

1

1 reference

13 August 2017

James F Leckman

series ordinal

2

1 reference

13 August 2017

Christopher Young

series ordinal

3

1 reference

13 August 2017

Andrés Martin

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

International Review of Neurobiology

13 August 2017

published in

1 reference

13 August 2017

volume

65

1 reference

13 August 2017

page(s)

25-52

1 reference

Mania induced by fluoxetine in an adolescent patient

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Developmental Pathways to Bipolarity: Are Juvenile-Onset Depressions Pre-Bipolar?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Genetic factors and treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Antidepressant-induced mania and cycle acceleration: a controversy revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Age at onset of selected mental disorders in five community populations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Drug-induced disinhibition in psychiatrically hospitalized children.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Noradrenergic and serotonergic neuroendocrine responses in prepubertal, peripubertal, and postpubertal rats pretreated with desipramine and sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Antidepressant exposure in bipolar children

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Tolerance to therapeutic effects of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

The long-term course of rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Serotonin reuptake inhibitor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Clinical Factors in Lithium Carbonate Prophylaxis Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Fluoxetine in child and adolescent depression: acute and maintenance treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Mania associated with venlafaxine discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Pharmacology of Antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Antidepressants in bipolar disorder: the case for caution

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Antidepressant treatment in bipolar versus unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Evidence-based pharmacotherapy of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Mania induced by sertraline in a prepubertal child.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

A permanent change in brain function resulting from daily electrical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Kindling in bipolar disorders: a longitudinal follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Antidepressant-induced mania: an overview of current controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Review of safety assessment methods used in pediatric psychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

1 reference

7 January 2021

Adult outcomes of childhood and adolescent depression. I. Psychiatric status

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

1 reference

7 January 2021

Antidepressant-induced mania in bipolar patients: identification of risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Clinical importance of long-term antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Induction of Mania With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

Efficacy and safety of antidepressants for children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2804%2965002-1

7 January 2021

10.1016/S0074-7742(04)65002-1

Identifiers

DOI

1 reference

13 August 2017

1 reference